{"id":"rupatadin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["Each tablet contains 10 mg RUP"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Platelet-activating factor receptor, Histamine H1 receptor"},"_scrapedAt":"2026-03-28T02:49:21.780Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Allergic rhinitis","diseaseId":"allergic-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urticaria","diseaseId":"urticaria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02358265","phase":"PHASE3","title":"Chronic Urticaria - Long Term Assessment of Effects of Rupatadine","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"2014-12","conditions":"Chronic Urticaria","enrollment":192},{"nctId":"NCT01481909","phase":"PHASE2, PHASE3","title":"Study on Mastocytosis for Rupatadine Treatment","status":"COMPLETED","sponsor":"Marcus Maurer","startDate":"2010-09","conditions":"Mastocytosis","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Hematology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_2","status":"active","brandName":"Rupatadin","genericName":"Rupatadin","companyName":"Marcus Maurer","companyId":"marcus-maurer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rupatadin is a small molecule that acts as a platelet-activating factor receptor antagonist. It has been studied for the treatment of mastocytosis and chronic urticaria in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}